Stock BDRX BIODEXA PHARMACEUTICALS PLC
Add to a list
To use this feature you must be a member
Log inSign up

News Biodexa Pharmaceuticals Plc

Equities

BDRX

US59564R7089

Market Closed - Nasdaq
Other stock markets
 16:30:01 2024-05-03 EDT 		5-day change 1st Jan Change
1.18 USD -4.84% Intraday chart for Biodexa Pharmaceuticals Plc -9.23% -55.97%
05-03 European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Set to Close Week Lower MT
05-02 European Equities Traded in the US as American Depositary Receipts Rise Modestly Higher in Thursday Trading MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Set to Close Week Lower
MT
European Equities Traded in the US as American Depositary Receipts Rise Modestly Higher in Thursday Trading
MT
European Equities Traded in the US as American Depositary Receipts Trend Modestly Lower in Wednesday Trading
MT
Biodexa’s Licensor Emtora to Announce Phase 2 Clinical Trial Results of eRapa™ in Familial Adenomatous Polyposis to be Presented at Prestigious 2024 Digestive Disease Week Annual Meeting
AQ
European Equities Traded in the US as American Depositary Receipts Nudge Higher in Monday Trading
MT
Sector Update: Health Care Stocks Edge Higher Late Afternoon
MT
Sector Update: Health Care Stocks Higher in Afternoon Trading
MT
European Equities Close Higher in Friday Trading; Anglo American Rejects BHP Takeover Bid
MT
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading, End Week Up 3.4%
MT
Biodexa Pharmaceuticals Gets Exclusive License for Phase 3 Ready Drug to Treat Familial Adenomatous Polyposis -- Shares Jump
MT
Biodexa Enters Into Exclusive License to eRapa™, a Phase 3 Ready Asset for the Treatment of Familial Adenomatous Polyposis (FAP)
AQ
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Thursday Trading
MT
European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading
MT
European Equities Traded in the US as American Depositary Receipts Jump in Tuesday Trading
MT
European Equities Traded in the US as American Depositary Receipts Rebound in Monday Trading
MT
Preliminary Results for the Year Ended 31 December 2023
AQ
Biodexa Pharmaceuticals Plc Reports Earnings Results for the Full Year Ended December 31, 2023
CI
European Equities Traded in the US as American Depositary Receipts Flat in Thursday Trading
MT
European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading
MT
European Equities Traded in the US as American Depositary Receipts Lower in Tuesday Trading
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BDRX Stock
  4. News Biodexa Pharmaceuticals Plc